Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT02629159 ×

NCT02629159

This funder is selected. Its supporting articles are shown below.

NCT026291591

Articles mentioning NCT02629159

1 articles · page 1 of 1

Immunogenicity of adjuvanted recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomised controlled trial substudy

rmdopen · abstract · 2025-08-12 · 1 matching annotations

79.8%

NCT02629159 rheumatoid arthritis upadacitinib herpes zoster SELECT-COMPARE background methotrexate methotrexate

…ound methotrexate.Methods Eligible patients in SELECT-COMPARE ( NCT02629159) receiving upadacitinib 15 mg QD and background methotrexate re…